Telormedix SA is a Swiss-based biopharmaceutical company formed to develop immuno-selective drugs for the treatment of cancer and other diseases. We will initially focus on drugs that have been previously tested in humans and have favorable safety profile. This approach will allow us to rapidly develop drugs designed to be concomitantly very selective and well tolerated.
Looking for a particular Telormedix employee's phone or email?
The Telormedix annual revenue was $1 million in 2026.
Telormedix is based in Bioggio, Ticino.
The NAICS codes for Telormedix are [32, 3254, 32541, 325].
The SIC codes for Telormedix are [283, 28].